Testing version — LOERadar is in active testing. Features and data may change.
RIFAPENTINE (RIFAPENTINE) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
RIFAPENTINE
ANDANot in Orange Book
RIFAPENTINE | A217042 | MACLEODS PHARMS LTD
Products (1)
#001 — 150MG
▴
TABLET;ORAL | Approved: Jun. 23, 2026
No patent or exclusivity listings for this strength.